• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2016 Fiscal Year Final Research Report

Elucidation of pathogenesis and development of therapy of lipodystrophy using human iPS cell-derived adipocytes

Research Project

  • PDF
Project/Area Number 25293211
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypePartial Multi-year Fund
Section一般
Research Field Metabolomics
Research InstitutionNational Cardiovascular Center Research Institute (2015-2016)
Kyoto University (2013-2014)

Principal Investigator

Hosoda Kiminori  国立研究開発法人国立循環器病研究センター, 病院, 部長 (40271598)

Co-Investigator(Renkei-kenkyūsha) TAKAHASHI Kazutoshi  京都大学, iPS細胞研究所, 講師 (80432326)
YAMASHITA Jun  京都大学, iPS細胞研究所, 教授 (50335288)
NAKAO Kazuki  東京大学, 医学研究科, 准教授 (20217657)
Ebihara Ken  自治医科大学, 医学研究科, 准教授 (70362514)
SONE Masakatssu  京都大学, 医学研究科, 特定准教授 (40437207)
SAKURAI Hidetoshi  京都大学, iPS細胞研究所, 講師 (80528745)
FUJIKURA Junji  京都大学, 医学研究科, 助教 (70378743)
NOGUCHI Michio  京都大学, 医学研究科, 特定講師 (00432394)
Project Period (FY) 2013-04-01 – 2017-03-31
Keywordsseipin / iPS細胞 / 脂肪細胞 / 脂肪萎縮症 / インスリン抵抗性
Outline of Final Research Achievements

Congenital generalized lipodystrophy (CGL) is an autosomal recessive disorder characterized by marked scarcity of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early-onset diabetes. Mutation of the BSCL2/SEIPIN gene causes congenital generalized lipodystrophy. iPS cells were generated from two patients with CGL. Upon adipogenic differentiation, BSCL2-iPS cells exhibited marked reduction of lipid droplet formation concomitant with diffuse cytoplasmic distribution of ADRP, compared with iPS cells from healthy individuals. Forced expression of BSCL2 not only rescued the lipid accumulation defects, but also restored cytoplasmic punctate localization of ADRP in BSCL2-iPS cells. Coimmunoprecipitation indicated SEIPIN interacted with ADRP.

Free Research Field

内分泌代謝内科学

URL: 

Published: 2018-03-22  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi